After Flat 4th Quarter, USANA Director Unloads $722,884 In Stock

 

USANA Health Sciences (NASDAQ:USNA) Insider Kevin Guest sold 10,160 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $71.15, for a total value  of $722,884.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares  of USANA Health Sciences (NASDAQ:USNA) traded up 0.06% on Thursday, hitting $72.31. 3,980 shares of the company’s stock traded hands. USANA Health Sciences has a 52-week low of $55.01 and a 52-week high of $92.00. The stock’s 50-day moving average is $73.1 and its 200-day moving average is $71.87. The company has a market cap of $1.007 billion and a P/E ratio of 13.32.

USANA Health Sciences (NASDAQ:USNA) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.30 by $0.15. The company had revenue  of $182.40 million for the quarter, compared to the consensus estimate of $185.85 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, analysts predict that USANA Health Sciences will post $5.65 earnings per share for the current fiscal year.

Separately, analysts at Zacks downgraded shares of USANA Health Sciences from an “outperform” rating to a “neutral” rating in a research note on Tuesday, April 8th. They now have a $79.50 price  target on the stock. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $79.38.

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.